Cargando…
Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
The chemically synthesized endoperoxide compound N-89 and its derivative N-251 were shown to have potent antimalarial activity. We previously demonstrated that N-89 and N-251 potently inhibited the RNA replication of hepatitis C virus (HCV), which belongs to the Flaviviridae family. Since antimalari...
Autores principales: | Ueda, Youki, Gu, Weilin, Dansako, Hiromichi, Kim, Hye-Sook, Yoshizaki, Sayaka, Okumura, Nobuaki, Ishikawa, Tomohiro, Nishitsuji, Hironori, Kato, Fumihiro, Hishiki, Takayuki, Satoh, Shinya, Ishii, Koji, Masuda, Michiaki, Shimotohno, Kunitada, Ikeda, Masanori, Kato, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047365/ https://www.ncbi.nlm.nih.gov/pubmed/30023438 http://dx.doi.org/10.1016/j.bbrep.2018.05.007 |
Ejemplares similares
-
Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities
por: Gu, Weilin, et al.
Publicado: (2021) -
High‐level expression of STING restricts susceptibility to HBV by mediating type III IFN induction
por: Dansako, Hiromichi, et al.
Publicado: (2018) -
Pharmacokinetic analysis of new synthetic antimalarial N-251
por: Okada, Kazuaki, et al.
Publicado: (2019) -
ULBP1 is induced by hepatitis C virus infection and is the target of the NK cell‐mediated innate immune response in human hepatocytes
por: Dansako, Hiromichi, et al.
Publicado: (2018) -
New Preclinical Antimalarial Drugs Potently Inhibit Hepatitis C Virus Genotype 1b RNA Replication
por: Ueda, Youki, et al.
Publicado: (2013)